Christopher J. DeRespino
Keine laufenden Positionen mehr
Profil
Christopher J.
DeRespino worked as an Executive Director of Business Development at Amgen, Inc. from 2018 to 2021.
Prior to that, he worked as a Director of Business Development at Onyx Pharmaceuticals, Inc. He also briefly served as the Chief Financial, Accounting & Business Officer at Adverum Biotechnologies, Inc. in 2021.
DeRespino received his undergraduate degree from The Johns Hopkins University and his MBA from The Leonard N Stern School of Business.
Ehemalige bekannte Positionen von Christopher J. DeRespino
| Unternehmen | Position | Ende |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Finanzdirektor/CFO | 27.08.2021 |
| AMGEN INC. | Corporate Officer/Principal | 01.02.2021 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - |
Ausbildung von Christopher J. DeRespino
| The Leonard N Stern School of Business | Masters Business Admin |
| The Johns Hopkins University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
